Coblopasvir
Coblopasvir is a pharmaceutical drug for the treatment of hepatitis C.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Coblopasvir is a pharmaceutical drug for the treatment of hepatitis C. It is a pan-genotypic inhibitor of HCV nonstructural protein 5A. In China, it is approved for use in combination with sofosbuvir for treating naïve or interferon‐experienced adults chronically monoinfected patients with HCV of genotype 1, 2, 3 and 6, with or without compensated cirrhosis.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330139558 under CC BY-SA 4.0; modifications have been made.